John A. Scarlett - Jun 16, 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for John A. Scarlett
Stock symbol
CTMX
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 06:46 PM
Next filing
Aug 5, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Award $0 +20K $0.00 20K Jun 16, 2021 Common Stock 20K $7.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.